Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human ...
Equity Insider News Commentary ? Global markets are undergoing a structural realignment as technology M&A volume surged to an ...
Regeneron is to collaborate with Inovio to investigate a three-way immunotherapy combination against glioblastoma multiforme (GBM), an aggressive and hard-to-treat brain tumour. Regeneron’s drug is ...
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its ...
TNXP Tonix Pharmaceuticals Holding Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results